NCT00646516View on ClinicalTrials.gov

Gemini Symbicort pMDI

PHASE3CompletedINTERVENTIONAL

Enrollment

615

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

February 28, 2005

Conditions

Mild or Moderate Asthma

Interventions

DRUG

budesonide/formoterol (Symbicort)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY